Skip to main content
SpringerLink
Log in

Kombination aus perkutaner Strahlentherapie, Brachytherapie und Androgendeprivation gleichwertige Alternative zur radikalen Prostatektomie beim Prostatakarzinom

Combination of percutaneous radiotherapy, brachytherapy, and androgen deprivation equivalent alternatives to radical prostatectomy for prostate cancer

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Kishan AU, Shaikh T, Wang PC, Reiter RE, Said J, Raghavan G et al (2017) Clinical outcomes for patients with Gleason score 9–10 prostate adenocarcinoma treated with radiotherapy or radical prostatectomy: a multi-institutional comparative analysis. Eur Urol 71:766–773

    Article  PubMed  Google Scholar 

  2. Morris WJ, Tyldesley S, Rodda S, Halperin R, Pai H, McKenzie M et al (2017) Androgen suppression combined with elective nodal and dose escalated radiation therapy (the ASCENDE-RT trial): an analysis of survival endpoints for a randomized trial comparing a low-dose-rate Brachytherapy boost to a dose-escalated external beam boost for high- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys 98:275–285

    Article  PubMed  Google Scholar 

  3. Zelefsky MJ, Eastham JA, Cronin AM, Fuks Z, Zhang Z, Yamada Y et al (2010) Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. J Clin Oncol 28:1508–1513

    Article  PubMed  PubMed Central  Google Scholar 

  4. Wallis CJD, Saskin R, Choo R, Herschorn S, Kodama RT, Satkunasivam R et al (2016) Surgery versus radiotherapy for clinically-localized prostate cancer: a systematic review and meta-analysis. Eur Urol 70:21–30

    Article  PubMed  Google Scholar 

  5. Johnson SB, Lester-Coll NH, Kelly JR, Kann BH, Yu JB, Nath SK (2017) Brachytherapy boost utilization and survival in unfavorable-risk prostate cancer. Eur Urol 72:738–744

    Article  PubMed  Google Scholar 

  6. Zelefsky MJ, Reuter VE, Fuks Z, Scardino P, Shippy A (2008) Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer. J Urol 179:1368–1373 (discussion 73)

    Article  PubMed  PubMed Central  Google Scholar 

  7. Martinez AA, Gonzalez J, Ye H, Ghilezan M, Shetty S, Kernen K et al (2011) Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with Hypofractionated high-dose-rate boost and external beam radiotherapy. Int J Radiat Oncol Biol Phys 79:363–370

    Article  PubMed  Google Scholar 

  8. Rodda S, Tyldesley S, Morris WJ, Keyes M, Halperin R, Pai H et al (2017) ASCENDE-RT: an analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys 98:286–295

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology Medical Center and Medical Faculty, University of Freiburg, Germany German Cancer Consortium (DKTK) Partner Site Freiburg, Freiburg, Deutschland

    Constantinos Zamboglou &  Anca Ligia Grosu

Authors
  1. Constantinos Zamboglou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anca Ligia Grosu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anca Ligia Grosu.

Ethics declarations

Interessenkonflikt

C. Zamboglou und A. L. Grosu geben an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation

Kishan AU, Shaikh T, Wang PC et al (2017) Clinical outcomes for patients with gleason score 9–10 prostate adenocarcinoma treated with radiotherapy or radical prostatectomy: a multi-institutional comparative analysis. Eur Urol 71:766–773

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zamboglou, C., Grosu, A.L. Kombination aus perkutaner Strahlentherapie, Brachytherapie und Androgendeprivation gleichwertige Alternative zur radikalen Prostatektomie beim Prostatakarzinom. Strahlenther Onkol 194, 360–362 (2018). https://doi.org/10.1007/s00066-018-1273-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-018-1273-7

Search

Navigation